 Biocept Inc NASDAQ:BIOC will present a multi-institutional case series on its CNSide cerebrospinal fluid assay at the upcoming Society for Neuro-Oncology annual meeting in Boston. The San Diego-based biotech company said it will show how CNSide helps physicians monitor treatment response and detects actionable mutations in patients with metastatic breast cancer and leptomeningeal disease LMD. 